27278134|t|Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction
27278134|a|The protective effect of dual antiplatelet therapy (DAPT) following acute coronary syndrome is undisputed, but its duration is subject of debate. Several studies show that prolonged therapy provides a clinical benefit in patients following acute coronary syndrome. The aim of this position paper authored by Austrian experts is to outline the current evidence and provide an overview of recent studies. It is also intended to serve as a practical guide to identify those patients who may benefit from prolonged DAPT.
27278134	0	6	Expert	T097	C1522486
27278134	7	21	position paper	T170	C0282574
27278134	25	34	prolonged	T079	C0439590
27278134	35	60	dual antiplatelet therapy	T061	C1096021
27278134	64	84	secondary prevention	T061	C0679699
27278134	95	116	myocardial infarction	T047	C0027051
27278134	121	138	protective effect	T080	C1280500
27278134	142	167	dual antiplatelet therapy	T061	C1096021
27278134	169	173	DAPT	T061	C1096021
27278134	185	208	acute coronary syndrome	T047	C0948089
27278134	232	240	duration	T079	C0449238
27278134	255	261	debate	T052	C0870392
27278134	271	278	studies	T062	C2603343
27278134	289	298	prolonged	T079	C0439590
27278134	299	306	therapy	T061	C0087111
27278134	318	326	clinical	T080	C0205210
27278134	327	334	benefit	T081	C0814225
27278134	338	346	patients	T101	C0030705
27278134	357	380	acute coronary syndrome	T047	C0948089
27278134	398	412	position paper	T170	C0282574
27278134	425	433	Austrian	T098	C0337795
27278134	434	441	experts	T097	C1522486
27278134	460	467	current	T079	C0521116
27278134	468	476	evidence	T078	C3887511
27278134	511	518	studies	T062	C2603343
27278134	554	569	practical guide	T170	C0681467
27278134	588	596	patients	T101	C0030705
27278134	605	612	benefit	T081	C0814225
27278134	618	627	prolonged	T079	C0439590
27278134	628	632	DAPT	T061	C1096021